Comment on Amarin stock heads toward highest prices in more than a decade after new Vascepa FDA approval

Amarin stock heads toward highest prices in more than a decade after new Vascepa FDA approval

Amarin Corp.’s stock rises in the extended session Friday after being halted for half the trading day as the pharmaceutical company hikes its sales outlook following a Food and Drug Administration marketing approval that gives its drug Vascepa a wider use.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News